The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...

Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in ...

Grace has announced the initial closing of a financing round, securing almost $15m, for funding pre-commercial development of ...

Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...

China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis ...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for ...